ArticleBlood cancer journal2023

Monitoring measurable residual disease and chimerism in patients with JAK2 V617F-positive myelofibrosis after allogeneic hematopoietic cell transplantation.

Jong-Mi Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.